This discovery revealed a novel regulatory mechanism, the LINC00511–YTHDF2–SOX2–LINC00511 positive feedback loop, that plays a critical role in the onset and progression of cholangiocarcinoma (Figure 7F). Here, LINC00511 is linked to cholangiocarcinoma.